Champagne and questions greet first data showing that a COVID-19 vaccine works
Pfizer and BioNTech announced groundbreaking mRNA vaccine is 90% effective but provide little data so far
Coronavirus
Read our COVID-19 research and news.
-
-
With inauguration 10 weeks away, Biden’s pandemic plans face agonizing wait
Crisis could get much worse before new administration takes power -
How a communist physics teacher flattened the COVID-19 curve in southern India
In Kerala state, health minister K. K. Shailaja is fighting to stem a new surge -
Will a small, long-shot U.S. company end up producing the best coronavirus vaccine?
Novavax vaccine shows “markedly stronger” responses in early human trials -
Europe is locking down a second time. But what is its long-term plan?
New measures seek to lower the spread of the coronavirus, but some scientists say Europe should eliminate it -
Gyms. Bars. The White House. See how superspreading events are driving the pandemic
Preventing hot spots of COVID-19 transmission has emerged as a key challenge in the fight against the virus -
India’s COVID-19 cases have declined rapidly—but herd immunity is still far away, scientists say
Encouraging national trends hide a complex picture of “100 epidemics,” some rising, some falling -
The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug
The Food and Drug Administration held no advisory meeting on antiviral, and the European Union signed contract without knowing of failed trial -
‘Another piece of populist propaganda’: Critics slam the Brazilian government’s new COVID-19 drug
A trial showed that nitazoxanide, an antiparasitic drug, lowers virus levels in patients. Scientists say it’s irrelevant -
‘Every minute counts.’ This immunologist rapidly reshaped her lab to tackle COVID-19
For Akiko Iwasaki, the pandemic has brought new research priorities—and new urgency -
‘There’s only one chance to do this right’—FDA panel wrestles with COVID-19 vaccine issues
Some committee members warn against emergency use of candidates not definitively proven safe or effective -
Podcast: Early approval of a COVID-19 vaccine could cause ethical problems, and ‘upcycling’ plastic bags
On this week’s show: Ethical dilemmas will abound for efficacy trials that continue after one COVID-19 vaccine proves itself, and turning plastic bags into biodegradable detergents -
Could certain COVID-19 vaccines leave people more vulnerable to the AIDS virus?
Cold-causing adenovirus used in four experimental COVID-19 vaccines increased risk of HIV infection when used in AIDS vaccine trials -
Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments
Solidarity fails to find mortality benefits in four treatments—but the global trial itself wins praise -
Podcast: Making sure American Indian COVID-19 cases are counted, and feeding a hungry heart
On this week’s show: A profile of a scientist fighting for her people to be counted, and quantifying how the heart uses fuel -
Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign
Trisha Greenhalgh argues COVID-19 shows how too much weight on evidence-based medicine can be the enemy of good policy
